"Lymphocyte Transfusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transfer of lymphocytes from a donor to a recipient or reinfusion to the donor.
| Descriptor ID |
D017710
|
| MeSH Number(s) |
E02.095.135.140.425.445
|
| Concept/Terms |
Lymphocyte Transfusion- Lymphocyte Transfusion
- Lymphocyte Transfusions
- Transfusion, Lymphocyte
- Transfusions, Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Lymphocyte Transfusion".
Below are MeSH descriptors whose meaning is more specific than "Lymphocyte Transfusion".
This graph shows the total number of publications written about "Lymphocyte Transfusion" by people in this website by year, and whether "Lymphocyte Transfusion" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 2 | 2 |
| 1998 | 2 | 0 | 2 |
| 2000 | 2 | 2 | 4 |
| 2001 | 2 | 0 | 2 |
| 2002 | 2 | 1 | 3 |
| 2003 | 0 | 3 | 3 |
| 2004 | 4 | 1 | 5 |
| 2005 | 1 | 0 | 1 |
| 2006 | 4 | 1 | 5 |
| 2007 | 4 | 1 | 5 |
| 2008 | 2 | 3 | 5 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2012 | 2 | 3 | 5 |
| 2013 | 1 | 2 | 3 |
| 2016 | 3 | 0 | 3 |
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 2 | 3 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphocyte Transfusion" by people in Profiles.
-
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021 05 13; 137(19):2585-2597.
-
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biol Blood Marrow Transplant. 2020 06; 26(6):1137-1143.
-
Conspicuous activated lymphocytic proliferation associated with cytokine-release syndrome after CAR T-cell therapy. Int J Hematol. 2018 11; 108(5):461-462.
-
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation. Clin Cancer Res. 2018 09 01; 24(17):4098-4109.
-
Efficacy of intracellular immune checkpoint-silenced DC vaccine. JCI Insight. 2018 02 08; 3(3).
-
Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer. Mol Ther. 2017 11 01; 25(11):2440-2451.
-
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2017 Aug; 23(8):1405-1410.
-
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival. Br J Haematol. 2017 05; 177(4):567-577.
-
Checkpoint inhibition and cellular immunotherapy in lymphoma. Hematology Am Soc Hematol Educ Program. 2016 Dec 02; 2016(1):390-396.
-
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood. 2016 12 08; 128(23):2624-2636.